UK's biggest drugmakers see surprise profit bump, even as pharma grapples with U.S. policies
CNBC
—
AstraZeneca and GSK, the U.K.'s second and ninth most valuable companies, both saw first-quarter profits beat expectations early Wednesday.
AstraZeneca beats expectations
- Astrazeneca tops expectations in the first quarter on strong cancer drug sales Associated Press —
- AstraZeneca posted stronger-than-expected profit and revenue on surging cancer drug sales Quartz —
- AstraZeneca makes surprise U-turn with £300m pharma investment The Guardian —
- Shot in the arm for GSK and AstraZeneca from cancer drug sales The Argus —
- Astrazeneca ploughs £300m into UK in surprise U-turn City AM —